IFG Advisory’s AstraZeneca AZN Stock Holding History

IFG Advisory’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$504K	Buy	+2,657	New	+$500K	0.02%	606
2018 Q4	–	Sell	-3,722	Closed	-$294K	–	319
2018 Q3	$294K	Sell	3,722 -432	-10%	-$32.7K	0.06%	299
2018 Q2	$291K	Sell	4,154 -21	-0.5%	-$1.51K	0.06%	275
2018 Q1	$291K	Sell	4,175 -993	-19%	-$68.8K	0.06%	274
2017 Q4	$358K	Buy	+5,168	New	+$349K	0.08%	231

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

IFG Advisory's AZN Position: Q2 2026 in Review

IFG Advisory opened a new position in AstraZeneca (AZN) in Q2 2026: 2,657 shares worth $504K. The stake represents 0.02% of the portfolio and ranks #606 among its holdings. This is a return to the name: IFG Advisory previously reported a position in AZN as recently as Q3 2018.

IFG Advisory first reported a position in AZN in Q4 2017 and has held it in 5 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

IFG Advisory held 2,657 shares of AstraZeneca worth $504K as of Q2 2026.
AstraZeneca was a new IFG Advisory position in Q2 2026.
AstraZeneca made up 0.02% of IFG Advisory's portfolio in Q2 2026, its #606 holding.
IFG Advisory first reported a position in AstraZeneca in Q4 2017 and has held it in 5 quarters since.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.